Gene therapy for heart transplantation-associated acute rejection, ischemia/reperfusion injury and coronary arteriosclerosis

Current Gene Therapy

Volumn 4, Issue 2, 2004, Pages 145-152

  Isobe, Mitsuaki ^a   Kosuge, Hisanori ^a   Koga, Noritaka ^a   Futamatsu, Hideki ^a   Suzuki, Jun Ichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Acute rejection; Chronic rejection; Gene therapy; Graft vasculopathy; Heart transplantation; Immunosuppression; Ischemia reperfusion injury; Tolerance

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; AZATHIOPRINE; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CELL ADHESION MOLECULE; CRE RECOMBINASE; CYCLIN DEPENDENT KINASE 2; CYCLOSPORIN; CYCLOSPORIN A; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DOUBLE STRANDED DNA; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN BCL 2; RAPAMYCIN; SCATTER FACTOR; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ACUTE GRAFT REJECTION; CHRONIC GRAFT REJECTION; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG RESPONSE; DRUG SPECIFICITY; DRUG TISSUE LEVEL; GENE CONTROL; GENE THERAPY; GENETIC TRANSFECTION; GRAFT FAILURE; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LETHALITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OPPORTUNISTIC INFECTION; ORGAN DONOR; QUALITY OF LIFE; RECIPIENT; REPERFUSION INJURY; REVIEW; RISK FACTOR; STRUCTURE ACTIVITY RELATION; SURVIVAL TIME; TREATMENT INDICATION;

EID: 3042654616     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523043346507     Document Type: Review

References (67)

1. Akalin, E. and Bromberg J.S. (2002) Gene therapy and solid-organ transplantation. Kidney Int., 61: Symposium I S56-S-60.
2. Belzer, F.O., D'Alessandro, A.M., Hoffmann, R.M., Knechtle, S.J., Reed, A., Pirsch, J.D., Kalayoglu, M. and Sollinger, H.W. (1992) The use of UW solution in clinical transplantation. A 4-year experience. Ann. Surg., 215: 579-585.
3. Bilbao, G., Contreras, J.L., Gomez-Navarro, J., Eckhoff, D.E., Mikheeva, G., Krasnykh, V., Hynes, T., Thomas, F.T., Thomas, J.M. and Curiel, D.T. (1999) Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation. Transplantation, 67: 775-783.
4. Billingham, R.E., Brent, L. and Medawar, P.B. (1953) 'Actively acquired tolerance' of foreign cells. Nature, 172: 603-607.
5. Bonham, C.A., Peng, L., Liang, X., Chen, Z., Wang, L., Ma, L., Hackstein, H., Robbins, P.D., Thomson, A.W., Fung, J.J., Qian, S. and Lu, L. (2002) Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol., 169: 3382-3391.
6. Brauner, R., Nonoyama, M., Laks, H., Drinkwater, D.C.Jr., McCaffery, S., Drak, T., Berk, A.J., Sen, L. and Wu, L. (1997) Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival. J. Thorac. Cardiovasc. Surg., 114: 923-933.
7. Chang, G.J., Liu, T., Feng, S., Bedoll, M., O'rourke, R.W., Schmidt, G., Roberts, J.P. and Stock, P.G. (2002) Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery, 132: 149-156.
8. Chen, W., Bennett, C.F., Wang, M.E., Dragun, D., Tian, L., Stecker, K., Clark, J.H., Kahan, B.D. and Stepkowski, S.M. (1999) Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury. Transplantation, 68: 880-887.
9. Cheung, S.T., Tsui, T.Y., Wang, W.L., Yang, Z.F., Wong, S.Y., Ip, Y.C. and Fan, S.T. (2002) Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J. Gastroenterol. Hepatol., 17: 1008-1014.
10. David, A., Chetritt, J., Guillot, C., Tesson, L., Heslan, J.M., Cuturi, M.C., Soulillou, J.P. and Anegon, I. (2000) Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther., 7: 505-510.
11. DeBruyne, L.A., Li, K., Chan, S.Y., Qin, L., Bishop, D.K. and Bromberg, J.S. (1998) Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther., 5: 1079-1087.
12. DeFranco, A.L. (1991) Signal transduction. Immunosuppressants at work. Nature, 352: 754-755.
13. Drazan, K.E., Olthoff, K.M., Wu, L., Shen, X.D., Gelman, A. and Shaked, A. (1996) Adenovirus-mediated gene transfer in the transplant setting: early events after orthotopic transplantation of liver allografts expressing TGF-beta1. Transplantation, 62: 1080-1084.
14. Echizenya, H., Yamashita, K., Takehara, M., Konishi, K., Nomura, M., Yanagida, N., Kitagawa, N., Kobayashi, T., Furukawa, H., Inobe, M., Uede, T. and Todo, S. (2001) Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats. Transplant Proc., 33: 183-184.
15. Feng, S., Quickel, R.R., Hollister-Lock, J., McLeod, M., Bonner-Weir, S., Mulligan, R.C. and Weir, G.C. (1999) Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. Transplantation, 67: 1607-1613.
16. Flanagan, W.M., Corthesy, B., Bram, R.J. and Crabtree, G.R. (1991) Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature, 352: 803-807.
17. Ghosh, S., Michael, J., May, M.J., Elizabeth, B. and Kopp, E.B. (1998) NF-kB and REL proteins: Evolutionarily Conserved Mediators of Immune Responses. Annu. Rev. Immunol., 16: 225-260.
18. Ghosh, S. and Karin, M. (2002) Missing Pieces in the NF-kB Puzzle. Cell, 109: S81-S96.
19. Giannoukakis, N., Bonham, C.A., Qian, S., Zhou, Z., Peng, L., Harnaha, J., Li, W., Thomson, A.W., Fung, J.J., Robbins, P.D. and Lu, L. (2000) Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol. Ther., 1: 430-437.
20. Gudmundsdottir, H. and Turka, L.A. (1999) T cell costimulatory blockade: new therapies for transplant rejection. J. Am. Soc. Nephrol., 10:1356-1365.
21. Guillot, C., Guillonneau, C. Mathieu, P., Gerdes, C.A., Menoret, S., Braudeau, C., Tesson, L., Renaudin, K., Castro, M.G., Lowenstein, P.R. and Anegon, I. (2002) Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J. Immunol., 168: 1600-1609.
22. Hancock, W.W., Buelow, R., Sayegh, M.H. and Turka, L.A. (1998) Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med., 4:1392-1396.
23. Hancock, W.W., Sayegh, M.H., Zheng, X.G., Peach, R., Linsley, P.S. and Turka, L.A. (1996) Costimulatory function and expression of CD40 ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA, 93: 13967-13972.
24. Hosenpud, J.D., Bennett, L.E., Keck, B.M., Fiol, B., Boucek, M.M. and Novick, R.J. (1999) The registry of the international society for heart and lung transplantation: sixteenth official report-1999. J. Heart Lung Transplant, 17: 611-626.
25. Isobe, M., Yagita, H., Okumura, K. and Ihara, A. (1992) Specific acceptance of cardiac allograft after treatment with anti-ICAM-1 and anti-LFA-1. Science, 255: 1125-1127.
26. Isobe, M., Suzuki, J., Yagita, H., Okumura, K., Yamazaki, S., Nagai, R., Yazaki, Y. and Sekiguchi, M. (1994) Immunosuppression to cardiac allografts and soluble antigens by anti vascular cell adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. J. Immunol., 153: 5810-5818.
27. Isobe, M., Suzuki, J., Yamazaki, S., Horie, S., Okubo, Y., Maemura, K., Yazaki, Y. and Sekiguchi, M. (1997) Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1 and LFA-1. Circulation, 96: 2247-2253.
28. Johnson, D.E., Alderman, E.L., Schroeder, J.S., Gao, S.Z., Hunt, S., DeCampli, W.M., Stinson, E. and Billingham, M. (1991) Transplant coronary artery disease: histologic correlations with angiographic morphology. J. Am. Coll. Cardiol., 17: 449-455.
29. Kato, Y., Yamataka, A., Yagita, H., Okumura, K., Fujiwara, T. and Miyano, T. (1996) Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 antibodies. Ann. Surg., 223: 94-100.
30. Katz, S.M., Bennett, F., Stecker, K., Clark, J.H., Pham, T., Wang, M.E., Kahan, B.D. and Stepkowski, S.M. (2000) ICAM-1 antisense oligodeoxynucleotide improves islet allograft survival and function. Cell. Transplant., 9: 817-828.
31. Kawauchi, M., Suzuki, J., Morishita, R., Wada, Y., Izawa, A., Tomita, N., Amano, J., Kaneda, Y., Ogihara, T., Takamoto, S. and Isobe, M. (2000) Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates. Circ. Res., 87: 1063-1068.
32. Kirk, A.D., Harlan, D.M., Armstrong, N.N., Davis, T.A., Dong, Y., Gray, G.S., Hong, X., Thomas, D., Fechner, Jr. J.H. and Knechtle, S.J. (1997) CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA, 94: 8789-8794.
33. Kita, Y., Li, X.K., Ohba, M., Funeshima, N., Enosawa, S., Tamura, A., Suzuki, K., Amemiya, H., Hayashi, S., Kazui, T. and Suzuki, S. (1999) Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. Transplantation, 68: 758-766.
34. Kosuge, H., Suzuki, J., Gotoh, R., Koga, N., Isobe, M., Inobe, M. and Uede, U. (2003) Specific acceptance of cardiac allografts by a combined treatment with inducible costimulator (ICOS) and CTLA4. Transplantation, 75: 1374-9.
35. Larsen, C.P., Elwood, E.T., Alexander, D.Z., Ritchie, S.C., Hendrix, R., Tucker-Burden C., Cho, H.R., Aruffo, A., Hollenbaugh, D., Linsley, P.S., Winn, K.J. and Pearson, T.C. (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature, 381: 434-438.
36. Larsen, C.P. and Pearson, T.C. (1997) The CD40 pathway in allograft rejection, acceptance and tolerance. Curr. Opin. Immunol., 9: 641-647.
37. Lenschow, D.J, Zheng, Y., Tistlethwaite, J.R., Montag, A, Brady, W., Gibson, M.G., Linsley, P.S. and Bluestone, J. A. (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science, 257: 789-792.
38. Li, J.M., Collins, L., Zhang, X., Gustafsson, K. and Fabre, J.W. (2000) Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplantation, 70: 1616-1624.
39. Madsen, J.C., Superina, R.A., Wood, K.J. and Morris, P.J. (1988) Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature, 332: 161-164.
40. Morishita, R., Gibbons, G.H., Ellison, K.E., Nakajima, M., Leyen, H., Zhang, L., Kaneda, Y., Ogihara, T. and Dzau, V.J. (1994) Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest., 93: 1458-1464.
41. Morishita, R., Gibbons, G.H., Horiuchi, M., Ellison, K.E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T. and Dzau, V.J. (1995) A novel molecular strategy using cis element "Decoy" of E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA, 92: 5855-5859.
42. Nomura, M., Yamashita, K., Murakami, M., Takehara, M., Echizenya, H., Sunahara, M., Kitagawa, N., Fujita, M., Furukawa, H., Uede, T. and Todo, S. (2002) Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation. Transplantation, 73: 1403-1410.
43. Olthoff, K.M., Judge, T.A., Gelman, A.E., Da, S. X., Hancock, W.W., Turka, L.A. and Shaked, A. (1998) Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat. Med., 4: 194-200.
44. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W. and Draetta, G. (1992) Cyclin A is required at two points in the human cell cycle. EMBO J., 11: 961-971.
45. Poston, R.S., Mann, M.L. Hoyt, E.G., Ennen, M., Dzau, V.J. and Robbins, R.C. (1999) Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. Transplantation, 68: 825-832.
46. Qin, L., Chavin, K.D., Ding, Y., Favaro, J.P., Woodward, J.E., Lin, J., Tahara, H., Robbins, P., Shaked, A., Ho, D.Y., Sapolsky, R.M., Lotze, M.T. and Bromberg, J. S. (1995) Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation, 59: 809-816.
47. Qin, L., Chavin, K.D., Ding, Y., Tahara, H., Favaro, J.P., Woodward, J.E., Suzuki, T., Robbins, P.D., Lotze, M.T. and Bromberg, J.S. (1996) Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol., 156: 2316-2323.
48. Qin, L. Ding, Y. and Bromberg, J.S. (1996) Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum. Gene Ther., 7: 1981-1988.
49. Rosato, A., Mandruzzato, S., Bronte, V., Zambon, A., Macino, B., Calderazzo, F., Zanovello, P. and Collavo, D. (1995) Role of anti-LFA-1 and anti-ICAM-1 combined MAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV). Int. J. Cancer, 61: 355-362.
50. Sawa, Y, Morishita, R., Suzuki, K., Kagisaki, K., Kaneda, Y., Maeda, R., Kadoba, K. and Matsuda, H. (1997) A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. Circulation, 96 (9 suppl): II 280-284.
51. Sayegh, M.H., Akalin, E., Hancock, W.W., Russell, M.E., Carpeter, C.B., Linsley, P.S. and Turka, L.A. (1995) CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med., 181: 1869-1874.
52. Stepkowski, S.M., Tu, Y., Condon, T.P. and Bennett, C.F. (1994) Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol., 153: 5336-5346.
53. Suzuki, J., Isobe, M., Aikawa, M., Kawauchi, M., Shiojima, I., Kobayashi, N., Tojo, A., Kimura, K., Nishikawa, T., Sakai, T., Sekiguchi, M., Yazaki, Y. and Nagai, R. (1996) Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts -A study in rat and monkey models. Circulation, 94: 1118-1124.
54. Suzuki, J., Isobe, M., Morishita, R., Aoki, M., Horie, S., Okubo, Y., Kaneda, Y., Sawa, Y., Matsuda, H., Ogihara, T. and Sekiguchi, M. (1997) Prevention of graft arteriopathy by antisense cdk2 kinase oligonucleotide. Nat. Med., 3: 900-903.
55. Suzuki, J., Isobe, M., Morishita, R., Nishikawa, T., Amano, J. and Kaneda, Y. (2000) Antisense Bcl-x oligonucleotide induces apoptosis and prevents arterial neointimal formation in murine cardiac allografts. Cardiovasc. Res., 45: 783-787.
56. Suzuki, J., Isobe, M., Morishita, R., Nishikawa, T., Amano, J. and Kaneda, Y. (2000) Prevention of cardiac allograft arteriosclerosis using antisense proliferating-cell nuclear antigen oligonucleotide. Transplantation, 70: 398-400.
57. Suzuki, J., Morishita, R., Amano, J., Kaneda, Y. and Isobe, M. (2000) Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts. Gene Ther., 7: 1847-1852.
58. Suzuki, K., Sawa, Y., Kaneda, Y., Ichikawa, H., Shirakura, R. and Matsuda, H. (1997) In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to ischemia-reperfusion injury in rat. J. Clin. Invest., 99: 1645-1650.
59. Takehara, M., Murakami, M., Inobe, M., Tanaka, K., Chikuma, S., Saito, I., Kanegae, Y., Yasunami, Y., Nakano, M., Yamashita, K., Todo, S. and Uede, T. (2001) Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and loxP. Hum. Gene Ther., 12: 415-426.
60. The 1998 annual report of the U.S. scientific registry of transplant recipients and the OPTN (Organ procurement and transplantation network). http://www.unos.org/
61. Ueda, H., Sawa, Y., Matsumoto, K., Kitagawa-Sakakida, S., Kawahira, Y., Nakamura, T., Kaneda, Y. and Matsuda, H. (1999) Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann. Thorac. Surg., 67: 1726-1731.
62. Ugurlu, M.M., Griffin, M.D., O'Brien, T., Tazelaar, H.D., Miller, V.M. and McGregor, C.G. (2001) The effects of CTLA-4Ig on acute lung allograft rejection: a comparison of intrabronchial gene therapy with systemic administration of protein. Transplantation, 71: 1867-1871.
63. von der Leyen, H.E., Gibbons, G.H., Morishita, R., Lewis, N.P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J.P. and Dzau, V.J. (1995) Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA, 92: 1137-1141.
64. Wong, W., Morris, P.J. and Wood, K.J. (1997) Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: Evidence for linked epitope suppression. Transplantation, 63: 1490-1494.
65. Yang, Z., Rostami, S., Koeberlein, B., Barker, C.F. and Naji, A. (1999) Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig. Transplantation, 67: 1517-1523.
66. Zhou, P., Hwang, K.W., Palucki, D.A., Guo, Z., Boothby, M., Newell, K.A. and Alegre, M.L. (2003) Impaired NF-kB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts. Am. J. Transplant, 3: 139-17.
67. Zwacka, R.M., Zhou, W., Zhang, Y., Darb, C.J., Dudus, L., Halldorson, J., Oberley, L. and Engelhardt, J.F. (1998) Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat. Med., 4: 698-704.